Fig. 8: Schematic illustrating the rapid human neuromuscular junction (NMJ) model and its application to amyotrophic lateral sclerosis (ALS) modeling. | Cell Death Discovery

Fig. 8: Schematic illustrating the rapid human neuromuscular junction (NMJ) model and its application to amyotrophic lateral sclerosis (ALS) modeling.

From: Rapid iPSC-derived neuromuscular junction model uncovers motor neuron dominance in amyotrophic lateral sclerosis cytopathy

Fig. 8

We developed human NMJ-like tissues within 12 days using cryopreserved motor neurons (MNs) and iPSC-derived skeletal myoblasts and employed this model in ALS studies. ALS-specific cytopathies similar to those observed in patient tissues were observed, and the critical role of MNs in initiating NMJ cytopathies in ALS was evaluated. This figure was generated using Microsoft PowerPoint.

Back to article page